GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
Contenido no disponible. Consulta la fuente original.
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.